Business Context and Reporting Period
Company: PainReform Ltd. (PRF Technologies Ltd.)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: January 2021
Date of Filing: January 6, 2021
Principal Executive Offices: Herzliya, Israel
Executive Appointment
The filing serves to distribute a press release announcing the appointment of Rita Keynan as Vice President of Pharmaceutical Operations.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a corporate event and does not contain financial statements.
Material Changes
Management Change: Appointment of Rita Keynan to the role of Vice President of Pharmaceutical Operations.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the professional background and experience of the newly appointed Vice President of Pharmaceutical Operations, Rita Keynan.
- Confirm if this appointment signals a strategic shift in the company's pharmaceutical development pipeline.
- Review the full text of the press release (Exhibit 99.1) for additional details on the scope of the new role.